Mersana Therapeutics MRSN
$ 2.06
-7.21%
Quarterly report 2024-Q3
added 11-13-2024
Mersana Therapeutics Income Statement 2011-2024 | MRSN
Annual Income Statement Mersana Therapeutics
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
575 M | 567 M | 310 M | 1.12 B | 304 M | 105 M | 181 M | - | - | - | - | - | - |
Shares |
116 M | 93.7 M | 70.6 M | 61.5 M | 43.5 M | 23 M | 12 M | - | - | - | - | - | - |
Historical Prices |
4.95 | 6.05 | 4.39 | 18.2 | 8.66 | 5.51 | 17.3 | - | - | - | - | - | - |
Net Income |
-172 M | -204 M | -170 M | -88 M | -28.2 M | -64.3 M | -38.7 M | -13.7 M | -16.4 M | - | - | - | - |
Revenue |
36.9 M | 26.6 M | 43 K | 828 K | 42.1 M | 10.6 M | 17.5 M | 25.2 M | 10.4 M | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
4.07 M | 3.33 M | 1.27 M | 359 K | 234 K | - | - | - | -89 K | - | - | - | - |
EBITDA |
1.52 M | 927 K | 855 K | 1.01 M | -29 M | -64.4 M | -38.7 M | -13.2 M | -16 M | - | - | - | - |
Operating Expenses |
217 M | 230 M | 169 M | 88.9 M | 72.3 M | 76.2 M | 57.2 M | - | - | - | - | - | - |
General and Administrative Expenses |
59.5 M | 57 M | 36.9 M | 21.9 M | 17.3 M | 16.3 M | 10.5 M | 6.98 M | 5.35 M | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Mersana Therapeutics
2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
123 M | 122 M | 121 M | 121 M | 116 M | 108 M | 105 M | 97.6 M | 95.8 M | 79.9 M | 73.7 M | 71.8 M | 69.6 M | 69 M | 68.6 M | 68.4 M | 60.7 M | 48 M | 47.9 M | 47.8 M | 47.7 M | 30.3 M | 23.2 M | 23.2 M | 23 M | 22.8 M | 22.8 M | 22.2 M | 1.41 M | 1.34 M | 1.29 M | 1.28 M | 1.25 M | 1.24 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-11.5 M | -24.3 M | - | -41.7 M | -54.3 M | -56.2 M | - | -59.8 M | -52.2 M | -47.3 M | - | -45.5 M | -40.9 M | -34.7 M | -28.8 M | -22.5 M | -28.8 M | -28.8 M | -16.2 M | -16.2 M | -16.2 M | -16.2 M | -22.4 M | -22.4 M | -22.4 M | -22.4 M | -14 M | -38.7 M | -38.7 M | -38.7 M | 1.26 M | -13.7 M | -13.7 M | -5.36 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
12.6 M | 2.29 M | - | 7.7 M | 10.7 M | 7.8 M | - | 5.57 M | 4.28 M | 2.04 M | - | 11 K | 11 K | 11 K | 10 K | 11 K | 796 K | 11 K | 42 K | 844 K | 202 K | 41 M | 1.19 M | 2.15 M | 4.19 M | 3.06 M | 3.26 M | 6.27 M | 3.73 M | 4.29 M | 12 M | 3.26 M | 6.22 M | 3.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | 1.02 M | 1.02 M | 983 K | - | 880 K | 760 K | 724 K | - | 98 K | 95 K | 93 K | 92 K | 92 K | 87 K | 88 K | 87 K | 107 K | 40 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | - | - | - | 319 K | - | 645 K | 432 K | 205 K | - | 644 K | 432 K | 226 K | - | 750 K | 494 K | 248 K | - | 963 K | 653 K | 337 K | - | 907 K | 565 K | 258 K | - | 673 K | 438 K | 209 K | - | 449 K | 265 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
24.7 M | 27.7 M | - | 51.6 M | 67.2 M | 65.6 M | - | 65.2 M | 56 M | 48.6 M | - | 45.4 M | 40.8 M | 34.6 M | 28.8 M | 22.4 M | 20.6 M | 17.2 M | 16.6 M | 18.1 M | 18 M | 19.6 M | 24 M | 19.6 M | 16.9 M | 15.8 M | 17.6 M | 14.3 M | 12.8 M | 12.4 M | 10.8 M | 9.15 M | 10 M | 9.06 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
9.86 M | 10.5 M | - | 12.9 M | 18.2 M | 18.3 M | - | 14.6 M | 14.8 M | 12.8 M | - | 10.1 M | 8.88 M | 7.21 M | 5.91 M | 5.88 M | 5.17 M | 4.94 M | 4.21 M | 4.44 M | 4.19 M | 4.44 M | 4.15 M | 4.38 M | 4.23 M | 3.57 M | 3.06 M | 2.9 M | 2.2 M | 2.3 M | 1.94 M | 1.6 M | 1.83 M | 1.62 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency